The first phase 3 readout with Spine BioPharma's drug candidate for chronic low back pain (CLBP) has proved disappointing, but the company still believes there is a way forward for the programme. The ...

Biogen is looking to the future of its spinal muscular atrophy (SMA) business, taking an Ionis-partnered candidate that could offer dosing just once a year into pivotal trials on the strength of ...

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Pfizer Inc. is one of them. Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to advance ...

CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...

Eli Lilly (LLY) and Company announced positive topline results from ACHIEVE-3, an open-label randomized Phase 3 clinical trial evaluating the safety and efficacy of orforglipron compared to oral ...

Defence minister Rajnath Singh hinted at the potential resumption of Operation Sindoor, emphasizing that any future terrorist activities from Pakistan would be met ...

Biotech firm aTyr Pharma Inc. (NASDAQ:ATYR) plummeted over 81% at last check on Monday, with a session volume of 34.7 million compared to the average volume of 4.83 million as per data from Benzinga ...

The Andhra Pradesh State Council of Higher Education (APSCHE) has released the AP EAMCET 2025 phase 3 and final seat allotment results at eapcet-sche.aptonline.in. Candidates must download their ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Moleculin Biotech ( (MBRX)) has provided ...

Across both STOP-HS1 and STOP-HS2, povorcitinib treatment resulted in continued clinically meaningful and statistically significant improvements for patients with active moderate to severe ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide, an investigational cereblon E3 ligase modulator (CELMoD™ ...

The 36 teams have discovered their fate for the UEFA Europa League league phase.